Jocelyn Côté is a Full Professor in the Department of Cellular and Molecular Medicine at the University of Ottawa, holding a concurrent role as Assistant Dean, Research and Special Projects in the Faculty of Medicine. His research focuses on the role of arginine methylation in RNA-binding proteins and its implications in neurodevelopmental disorders, neuromuscular diseases, and cancer. He leads studies on the molecular pathways underlying spinal muscular atrophy, myotonic dystrophy, and cancer progression, with particular emphasis on Tudor domain-containing proteins and PRMT enzymes. Education: B.Sc. Biochemistry (Université de Sherbrooke, 1992), Ph.D. Molecular Biology (Université de Sherbrooke, 1998), Postdoctoral Fellowships at Washington University and McGill. Research interests include: (1) arginine methylation regulation in RNA processing, (2) Tudor domain protein functions in disease, and (3) cancer-related epigenetic pathways. His work integrates cell biology, molecular genetics, and proteomics to identify novel therapeutic targets. Publications emphasize RNA biology and disease mechanisms, with recent work highlighting Staufen1's role in myotonic dystrophy and PRMT7's contribution to breast cancer metastasis. While no awards are explicitly listed, his research has implications for neuromuscular and oncological therapies. He collaborates with the Centre for Neuromuscular Diseases and the uOttawa Brain & Mind Research Institute, advancing translational research in neurodegenerative and neuromuscular disorders.









